Physician profile
Asmabanu Patel
NPI 1831722347
$779.20
in general payments reported to CMS, 2019-2025
16 companies · $55.24 in 2025
The $55.24 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $124 · 2024: $600 · 2025: $55.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $117.33 | 2024-2025 | Apretude |
| Pfizer INC. | $85.30 | 2024 | |
| Abbvie INC. | $65.78 | 2024 | |
| Tris Pharma INC | $65.47 | 2023-2024 | Dyanavel Xr |
| Novo Nordisk INC | $62.17 | 2024 | Wegovy, Rybelsus, Ozempic |
| Gilead Sciences, INC. | $58.20 | 2024 | |
| Lilly USA, LLC | $56.27 | 2024 | Zepbound |
| Exact Sciences Corporation | $48.90 | 2024 | Cologuard Collection Kit |
| Corium, LLC | $45.06 | 2023 | Azstarys |
| Neos Therapeutics, LP | $40.30 | 2023-2024 | Adzenys Xr-Odt |
| Otsuka America Pharmaceutical, INC. | $35.93 | 2023-2024 | Rexulti |
| Lundbeck LLC | $25.75 | 2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $20.23 | 2024 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $19.51 | 2024 | |
| Coopersurgical, INC. | $17.27 | 2023 | Paragard T 380a |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asmabanu Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.